Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis

被引：0
|
作者：
T. Sugimoto
T. Nakamura
Y. Nakamura
Y. Isogai
M. Shiraki
机构：
[1] Shimane University,Internal Medicine 1, Faculty of Medicine
[2] National Center for Global Health and Medicine,Project for Bone Metabolic Disease
[3] Asahi Kasei Pharma Corporation,undefined
[4] Research Institute and Practice for Involutional Diseases,undefined
来源：
Osteoporosis International | 2014年 / 25卷
关键词：
Bone formation; Bone resorption; Calcium metabolism; Human; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1173 / 1180
页数：7
相关论文
共 50 条
  • [21] The change of bone markers after once-weekly low dose alendronate in postmenopausal women with moderate bone loss
    Choi, H.
    Kim, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S326 - S326
  • [22] Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis
    Recker, Robert R.
    Marin, Fernando
    Ish-Shalom, Sophia
    Moericke, Ruediger
    Hawkins, Federico
    Kapetanos, Georgios
    de la Pena, Maria P.
    Kekow, Joern
    Farrerons, Jordi
    Sanz, Beatriz
    Oertel, Heide
    Stepan, Jan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (08) : 1358 - 1368
  • [23] Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
    Shiraki, M.
    Sugimoto, T.
    Nakamura, T.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (01) : 219 - 226
  • [24] Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
    M. Shiraki
    T. Sugimoto
    T. Nakamura
    Osteoporosis International, 2013, 24 : 219 - 226
  • [25] Once-weekly oral ibandronate prevents bone loss in postmenopausal women.
    Tankó, LB
    Riis, BJ
    Felsenberg, D
    Czerwinski, E
    Burdeska, A
    Jonkanski, I
    Hughes, C
    Christiansen, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S89 - S89
  • [26] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Uebelhart, B
    Foldes, J
    Peverly, C
    Santora, A
    Kaur, A
    Wu, M
    Orloff, J
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 25 - 25
  • [27] Bone density changes with once weekly risedronate in postmenopausal women
    Delaney, MF
    Hurwitz, S
    Shaw, J
    LeBoff, MS
    JOURNAL OF CLINICAL DENSITOMETRY, 2003, 6 (01) : 45 - 50
  • [28] Endotoxin and bone turnover markers in postmenopausal women with and without osteoporosis
    Aziz, Ibrahim
    Yakout, Sobhy M.
    Aljohani, Naji
    Al-Saleh, Yousef
    Al-Attas, Omar S.
    Alokail, Majed S.
    Amer, Osama E.
    Sheshah, Eman
    McTernan, Philip G.
    Al-Daghri, Nasser M.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10682 - 10687
  • [29] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Foldes, J
    Uebelhart, B
    Peverly, C
    Santora, A
    Kaur, A
    Wu, M
    Orloff, J
    BONE, 2001, 28 (05) : S94 - S94
  • [30] BONE MINERAL DENSITY AND BONE TURNOVER MARKERS AFTER ONE-YEAR TERIPARATIDE TREATMENT IN KOREAN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Oh, H.
    Choi, W.
    Choi, H.
    Kim, J.
    Lim, S.
    Joo, I.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 183 - 184
12345